Skip to main content
. 2024 May 2;11:1356283. doi: 10.3389/fmed.2024.1356283

Table 1.

Characteristics of severe COVID-19 patients at admission.

Variable Normal range All (n = 87) Survivors (n = 56) Non-survivors (n = 31) p
Age (years) 73 (63, 89) 73.5 (65, 89) 72 (60, 87.5) 0.598
Male/female 55/32 36/20 19/12 0.964
White blood cells (×109/L) 3.5–9.5 8.6 (6.4, 13.6) 7.7 (6.2, 12.5) 10.3 (7.9, 16.1) 0.03
Neutrophils (×109/L) 2.5–7.5 7.8 (5.1, 11.4) 6.3 (4.9, 10.8) 9.7 (6.8, 14.9) 0.045
Lymphocytes (×109/L) 0.8–4 0.8 (0.5, 1.1) 0.8 (0.5, 1.1) 0.6 (0.4, 1.1) 0.373
Hemoglobin (g/L) 115–150 93.6 ± 21.2 93 ± 22.8 94.6 ± 18.2 0.72
CRP (mg/L) 0–4 65.4 (26.6, 103.3) 55.2 (17.6, 81.4) 103.3 (44.1, 144.4) < 0.001
TBil (μmoI/L) 0–21 12.0 (7.4–23.4) 11.2 (7.0–17.5) 13.5 (10.7–45.7) 0.072
AST (U/L) 7–45 32.4 (23.2, 84.3) 29 (22.6, 47.4) 63.9 (28.9, 170.1) 0.006
ALT (U/L) 7–40 27.8 (17.7, 50.9) 23.6 (17.2, 40.4) 37.9 (20.4, 93) 0.039
SCr (μmoI/L) 41–81 75.4 (53.8, 156.1) 67.1 (48.7, 104.8) 100.8 (70.2, 179.3) 0.02
PLT (×109/L) 125–350 172 (72.5, 235.5) 195.5 (105, 247.8) 120 (64, 194) 0.048
APTT (s) 21–37 32.7 (29.6, 38.3) 31.7 (28.7, 35.7) 37.2 (31.5, 42.9) 0.002
PT (s) 9.2–15 14.2 (12.8, 15.9) 13.9 (12.7, 15) 15.3 (13.6, 20) 0.002
INR 0.8–1.25 1.2 (1.1, 1.3) 1.1 (1.1, 1.2) 1.3 (1.1, 1.7) 0.002
FIB (g/L) 2–4 4.9 (3.8, 13.5) 4.8 (3.8, 8.5) 5.3 (4.1, 13.9) 0.28
TT (s) 10–20 15.1 (4.6, 16.3) 14.9 (10.8, 16) 15.2 (4.1, 17.5) 0.556
D-Dimer (μg/mL) 0–0.55 2.3 (0.8, 5) 1 (0.4, 3) 5.3 (2.7, 16) <0.001

Values are n, mean ± SD, or median (interquartile range), unless otherwise noted. ALT, Alanine aminotransferase; APTT, Activated partial thromboplastin time; AST, Aspartate aminotransferase; CRP, C-reactive protein; FIB, Fibrinogen; HGB, Hemoglobin concentration; INR, International normalized ratio; PLT, Platelet count; PT, Prothrombin time; SCr, Serum creatinine; TBil, Total bilirubin; TT, Thrombin time.